Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions
Authors
Keywords
-
Journal
AUTOIMMUNITY REVIEWS
Volume 22, Issue 11, Pages 103451
Publisher
Elsevier BV
Online
2023-09-23
DOI
10.1016/j.autrev.2023.103451
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low-dose intravenous immunoglobulin for children with newly diagnosed immune thrombocytopenia: protocol of a systematic review and meta-analysis
- (2023) Xiangge Ren et al. BMJ Open
- Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies
- (2022) Siw L. Ernstsen et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Efficacy and safety of intravenous immunoglobulin in patients with lupus nephritis: A systematic review of the literature
- (2022) Jairo Cajamarca-Barón et al. AUTOIMMUNITY REVIEWS
- Trial of Intravenous Immune Globulin in Dermatomyositis
- (2022) Rohit Aggarwal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Different initial IVIG Regimens in Kawasaki Disease
- (2021) Lan He et al. PEDIATRICS INTERNATIONAL
- Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis
- (2021) Adi Wilf-Yarkoni et al. JOURNAL OF NEUROLOGY
- Stratified therapy for Kawasaki disease using a new scoring system to predict the response to a lower dose of intravenous immunoglobulin therapy
- (2021) Misa Matsuura et al. CARDIOLOGY IN THE YOUNG
- Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis
- (2021) Rudra Prosad Goswami et al. AUTOIMMUNITY REVIEWS
- A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR ‘Flash‐Mob’ retrospective study incorporating 961 patients
- (2021) et al. BRITISH JOURNAL OF HAEMATOLOGY
- Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
- (2021) Marinos C. Dalakas Neurotherapeutics
- Autoimmune bullous skin diseases, pemphigus and pemphigoid
- (2020) Shohei Egami et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Chronic immunoglobulin maintenance therapy in myasthenia gravis
- (2020) M. Alcantara et al. EUROPEAN JOURNAL OF NEUROLOGY
- High-dose versus low-dose intravenous immunoglobulin for treatment of children with Kawasaki disease weighing 25 kg or more
- (2020) Takanori Suzuki et al. EUROPEAN JOURNAL OF PEDIATRICS
- High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
- (2019) Jochen H. O. Hoffmann et al. Frontiers in Immunology
- Optimization of intravenous immune globulin use at a comprehensive cancer center
- (2019) Bradley S Figgins et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Outcomes Associated With Standardized Ideal Body Weight Dosing of Intravenous Immune Globulin in Hospitalized Patients: A Multicenter Study
- (2019) Jeremy W. Grindeland et al. ANNALS OF PHARMACOTHERAPY
- Next-generation Fc receptor–targeting biologics for autoimmune diseases
- (2019) Adrian W. Zuercher et al. AUTOIMMUNITY REVIEWS
- Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a single-center experience with 63 patients
- (2019) I Nieto-Aristizábal et al. LUPUS
- Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?
- (2019) Jeffrey A. Allen et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins)
- (2018) Saskia Ingen-Housz-Oro et al. Orphanet Journal of Rare Diseases
- IVIG-mediated effector functions in autoimmune and inflammatory diseases
- (2017) Caroline Galeotti et al. INTERNATIONAL IMMUNOLOGY
- Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology—Thirty Years of Progress but Still Much to Be Done
- (2017) Robert S. Stern et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Intravenous immunoglobulin: a biological corticosteroid-sparing agent in some autoimmune conditions
- (2017) A Watad et al. LUPUS
- Netherton Syndrome Mimicking Pustular Psoriasis: Clinical Implications and Response to Intravenous Immunoglobulin
- (2016) Alison M. Small et al. PEDIATRIC DERMATOLOGY
- Lower-dose intravenous immunoglobulins for the treatment of fetal and neonatal alloimmune thrombocytopenia: a cohort study
- (2016) Marije Kamphuis et al. TRANSFUSION
- Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases
- (2015) Zeping Zhou et al. AUTOIMMUNITY
- Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized Trial
- (2015) Noortje P. Paridaans et al. FETAL DIAGNOSIS AND THERAPY
- Subcutaneous IgG in immune-mediate diseases: proposed mechanisms of action and literature review
- (2014) Maria Giovanna Danieli et al. AUTOIMMUNITY REVIEWS
- Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction
- (2014) Robert D. M. Hadden et al. Therapeutic Advances in Neurological Disorders
- Immune Thrombocytopenia
- (2013) Gaurav Kistangari et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Low dose intravenous immunoglobulins and steroids in toxic epidermal necrolysis: A prospective comparative open-labelled study of 36 cases
- (2013) K Sobhanakumari et al. Indian Journal of Dermatology Venereology & Leprology
- Maintenance IVIg therapy in myasthenia gravis does not affect disease activity
- (2013) M.A. Hellmann et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
- (2012) Erwin W. Gelfand NEW ENGLAND JOURNAL OF MEDICINE
- B cells are resistant to immunomodulation by ‘IVIg-educated’ dendritic cells
- (2011) Mohan S. Maddur et al. AUTOIMMUNITY REVIEWS
- Long-Term Therapy with Intravenous Immunoglobulin is Beneficial in Patients with Autoimmune Diseases
- (2011) Gisele Zandman-Goddard et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials
- (2010) Yuan-Han Qin et al. BLOOD COAGULATION & FIBRINOLYSIS
- Effectiveness of Medium-Dose Intravenous Immunoglobulin (1 g/kg) in the Treatment of Kawasaki Disease
- (2010) Joong-Seok Yeo et al. Korean Circulation Journal
- Comèl-Netherton syndrome defined as primary immunodeficiency
- (2009) Ellen D. Renner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis
- (2008) Wen-Hung Chung et al. NATURE MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started